Research graph
References from Neonatal growth with fish oil or mixed oil lipid emulsions in intestinal failure associated liver disease. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1097/mpg.0000000000001722
10.1097/mpg.0000000000001722 · External reference
ASPEN definitions in pediatric intestinal failure
10.1002/jpen.2232 · 2022 · External reference
Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review
10.1177/0148607113496280 · 2014 · External reference
The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis
10.1177/0148607111413598 · 2011 · External reference
Pediatric smoflipid therapy: patient response and safety concerns
10.1002/jpen.1929 · 2021 · External reference
Low-dose parenteral soybean oil for the prevention of parenteral nutrition-associated liver disease in neonates with gastrointestinal disorders
10.1177/0148607115588334 · 2017 · External reference
Soybean-oil lipid minimization for prevention of intestinal failure-associated liver disease in late-preterm and term infants with gastrointestinal surgical disorders
10.1002/jpen.2004 · 2021 · External reference
Lipid strategies to prevent intestinal failure-associated liver disease in neonates: a pilot trial
10.1002/jpen.2483 · 2023 · External reference
High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy
10.1016/j.jpeds.2012.10.019 · 2013 · External reference
Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury
10.1097/sla.0b013e3181b36657 · 2009 · External reference
Unresolved reference
External reference
Intravenous fish oil monotherapy as a source of calories and fatty acids promotes age-appropriate growth in pediatric patients with intestinal failure-associated liver disease
10.1016/j.jpeds.2019.12.065 · 2020 · External reference
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates
10.1016/j.clnu.2018.06.947 · 2018 · External reference
Growth in infants and children with intestinal failure-associated liver disease treated with intravenous fish oil
10.1097/mpg.0000000000002551 · 2020 · External reference
Exclusive fish oil lipid emulsion rescue strategy improves cholestasis in neonates on partially fish oil-based lipid emulsion: a pilot study
10.3390/nu15030509 · 2023 · External reference
Standards for levels of neonatal care: II, III, and IV
10.1542/peds.2023-061957 · 2023 · External reference
The REDCap consortium: building an international community of software platform partners
10.1016/j.jbi.2019.103208 · 2019 · External reference
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support
10.1016/j.jbi.2008.08.010 · 2009 · External reference
A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants
10.1186/1471-2431-13-59 · 2013 · External reference
Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants
10.1542/peds.2005-1368 · 2006 · External reference
A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis
10.1159/000358267 · 2014 · External reference
The weight for length in late preterm infants assessed with bioelectrical impedance is positively associated with anthropometric variables
2023 · External reference
Weight for length measures may not accurately reflect adiposity in preterm infants born appropriate for gestational age during hospitalisation or after discharge from the neonatal intensive care unit
10.1111/ijpo.12744 · 2021 · External reference
104: Conversion from SMOFlipid® to Omegaven® as a salvage therapy for severe intestinal failure associated liver disease
10.1097/01.tp.0000945872.19188.c3 · 2023 · External reference
Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences
10.1177/0884533616662996 · 2016 · External reference
Fish oil-based lipid emulsions in the treatment of parenteral nutrition-associated liver disease: an ongoing positive experience
10.3945/an.113.004671 · 2014 · External reference
Essential fatty acid deficiency in parenteral nutrition: historical perspective and modern solutions, a narrative review
10.1002/ncp.11278 · 2025 · External reference
Essential fatty acid status in surgical infants receiving parenteral nutrition with a composite lipid emulsion: a case series
10.1002/jpen.1311 · 2019 · External reference
Essential fatty acid deficiency with SMOflipid reduction in an infant with intestinal failure-associated liver disease
10.1002/jpen.1432 · 2019 · External reference
Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients
10.1097/mpg.0b013e3181bbf51e · 2010 · External reference
Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition
10.1016/j.clnu.2005.05.020 · 2005 · External reference
Sustained neonatal inflammation is associated with poor growth in infants born very preterm during the first year of life
10.1016/j.jpeds.2018.09.032 · 2019 · External reference
